ETS-1 Transcription Factor Binds Cooperatively to the Palindromic Head to Head ETS-binding Sites of the Stromelysin-1 Promoter by Counteracting Autoinhibition*

Stromelysin-1 (matrix metalloproteinase-3) is a member of the matrix metalloproteinase family. Regulation of its gene expression is critical for tissue homeostasis. Patterns of increased co-expression of stromelysin-1 and ETS-1 genes have been observed in pathological processes. Stromelysin-1 promoter is transactivated by ETS proteins through two palindromic head to head ETS-binding sites, an unusual configuration among metalloproteinase promoters. By using surface plasmon resonance, electrophoretic mobility shift assay, and photo-cross-linking, we showed that full-length human ETS-1 (p51) binds cooperatively to the ETS-binding site palindrome of the human stromelysin-1 promoter, with facilitated binding of the second ETS-1 molecule to form an ETS-1·DNA·ETS-1 ternary complex. The study of N-terminal deletion mutants allowed us to conclude that cooperative binding implied autoinhibition counteraction, requiring the 245–330-residue region of the protein that is encoded by exon VII of the gene. This region was deleted in the natural p42 isoform of ETS-1, which was unable to bind cooperatively to the palindrome. Transient transfection experiments showed a good correlation between DNA binding and promoter transactivation for p51. In contrast, p42 showed a poorer transactivation, reinforcing the significance of cooperative binding for full transactivation. It is the first time that ETS-1 was shown to be able to counteract its own autoinhibition.

[1]  B. Graves,et al.  Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition. , 2000, Genes & development.

[2]  B. Wasylyk,et al.  The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins. , 1991, The EMBO journal.

[3]  A. Ivanoff,et al.  Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines , 2001, International journal of cancer.

[4]  M Tilley,et al.  A simple modification of Blum's silver stain method allows for 30 minute detection of proteins in polyacrylamide gels. , 1994, Journal of biochemical and biophysical methods.

[5]  R. Kodandapani,et al.  New Insights on DNA Recognition by ets Proteins from the Crystal Structure of the PU.1 ETS Domain-DNA Complex* , 1996, The Journal of Biological Chemistry.

[6]  A. Seth,et al.  Ets transcription factors and targets in osteogenesis , 2000, Oncogene.

[7]  T. Noumi,et al.  Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. , 1995, Oncogene.

[8]  B. Graves,et al.  Specificity within the ets family of transcription factors. , 1998, Advances in cancer research.

[9]  T. Gu,et al.  Auto-Inhibition of Ets-1 Is Counteracted by DNA Binding Cooperativity with Core-Binding Factor α2 , 2000, Molecular and Cellular Biology.

[10]  M. Rivera,et al.  A Role for CREB Binding Protein and p300 Transcriptional Coactivators in Ets-1 Transactivation Functions , 1998, Molecular and Cellular Biology.

[11]  T. Graf,et al.  Mutual activation of Ets‐1 and AML1 DNA binding by direct interaction of their autoinhibitory domains , 1999, The EMBO journal.

[12]  B. Vandenbunder,et al.  The Ets family contains transcriptional activators and repressors involved in angiogenesis. , 2001, The international journal of biochemistry & cell biology.

[13]  Thiennu H. Vu,et al.  Matrix metalloproteinases: effectors of development and normal physiology. , 2000, Genes & development.

[14]  T. Kodadek,et al.  Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Graf,et al.  Cooperative interaction of Ets‐1 with USF‐1 required for HIV‐1 enhancer activity in T cells , 1998, The EMBO journal.

[16]  D. Pinkel,et al.  The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.

[17]  M. Kurkinen,et al.  A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene. , 1993, The Journal of biological chemistry.

[18]  T. Johansen,et al.  The Nuclear Factor SPBP Contains Different Functional Domains and Stimulates the Activity of Various Transcriptional Activators* , 2000, The Journal of Biological Chemistry.

[19]  D. Stéhelin,et al.  Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. , 1996, Oncogene.

[20]  A. Henney,et al.  Human stromelysin gene promoter activity is modulated by transcription factor ZBP‐89 , 1999, FEBS letters.

[21]  F. Bartel,et al.  Mouse models in the study of the Ets family of transcription factors , 2000, Oncogene.

[22]  M. Razzaque,et al.  Renal expression of the Ets-1 proto-oncogene during progression of rat crescentic glomerulonephritis. , 2000, Journal of the American Society of Nephrology : JASN.

[23]  B. Fingleton,et al.  The PEA3 Subfamily of Ets Transcription Factors Synergizes with β-Catenin–LEF-1 To Activate Matrilysin Transcription in Intestinal Tumors , 2001, Molecular and Cellular Biology.

[24]  R. Marmorstein,et al.  Structures of SAP-1 bound to DNA targets from the E74 and c-fos promoters: insights into DNA sequence discrimination by Ets proteins. , 1998, Molecular cell.

[25]  T. Gu,et al.  Auto-Inhibition and Partner Proteins, Core-Binding Factor β (CBFβ) and Ets-1, Modulate DNA Binding by CBFα2 (AML1) , 2000, Molecular and Cellular Biology.

[26]  S. Zucker,et al.  Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment , 2000, Oncogene.

[27]  M. Gröger,et al.  Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alpha. , 2001, Arthritis and rheumatism.

[28]  M. Abe,et al.  ETS‐1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3 , 1999, Journal of cellular physiology.

[29]  A. Mauviel Cytokine regulation of metalloproteinase gene expression , 1993, Journal of cellular biochemistry.

[30]  B. Graves,et al.  Characterization of the cooperative function of inhibitory sequences in Ets-1 , 1996, Molecular and cellular biology.

[31]  J. Ghysdael,et al.  Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity. , 1994, The Journal of biological chemistry.

[32]  T. Hattori,et al.  Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer’s disease brain , 2000, Acta Neuropathologica.

[33]  A. Seth,et al.  Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody. , 1993, Oncogene.

[34]  L. McIntosh,et al.  Inhibitory Module of Ets-1 Allosterically Regulates DNA Binding through a Dipole-facilitated Phosphate Contact* , 2002, The Journal of Biological Chemistry.

[35]  A. Sharrocks,et al.  The ETS-domain transcription factor family. , 1997, Nature reviews. Molecular cell biology.

[36]  J. Erickson,et al.  Real‐time DNA binding measurements of the ETSl recombinant oncoproteins reveal significant kinetic differences between the p42 and p51 isoforms , 1994, Protein science : a publication of the Protein Society.

[37]  D. Stéhelin,et al.  The Ets Transcription Factors Interact with Each Other and with the c-Fos/c-Jun Complex via Distinct Protein Domains in a DNA-dependent and -independent Manner* , 1997, The Journal of Biological Chemistry.

[38]  B. Fingleton,et al.  Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  M. Gillespie,et al.  Autoinhibition as a transcriptional regulatory mechanism. , 1998, Cold Spring Harbor symposia on quantitative biology.

[40]  B. Wasylyk,et al.  Sp100 Interacts with ETS-1 and Stimulates Its Transcriptional Activity , 2002, Molecular and Cellular Biology.

[41]  B. Vandenbunder,et al.  Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. , 1994, Cancer research.

[42]  L. McIntosh,et al.  Structural coupling of the inhibitory regions flanking the ETS domain of murine Ets‐1 , 1996, Protein science : a publication of the Protein Society.

[43]  E. Hay,et al.  Guidebook to the extracellular matrix and adhesion proteins , 1995 .

[44]  B. Erman,et al.  Transcriptional Activation by ETS and Leucine Zipper-Containing Basic Helix-Loop-Helix Proteins , 1999, Molecular and Cellular Biology.

[45]  Ioanna G Maroulakou,et al.  Expression and function of Ets transcription factors in mammalian development: a regulatory network , 2000, Oncogene.

[46]  A. Seth,et al.  ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction. , 1996, Oncogene.

[47]  J. Lautenberger,et al.  Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation. , 1996, Oncogene.

[48]  M. Lark,et al.  Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. , 1992, The Journal of biological chemistry.

[49]  L. Matrisian,et al.  TEL, a Putative Tumor Suppressor, Modulates Cell Growth and Cell Morphology of Ras-Transformed Cells While Repressing the Transcription of stromelysin-1 , 2000, Molecular and Cellular Biology.

[50]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[51]  T. Graf,et al.  DNA binding by c‐Ets‐1, but not v‐Ets, is repressed by an intramolecular mechanism. , 1992, The EMBO journal.

[52]  H. Yokota,et al.  Messenger-RNA expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and transcription factors in rheumatic synovial cells under mechanical stimuli. , 2001, Bone.

[53]  S. Weitzman,et al.  p300/cAMP-responsive Element-binding Protein Interactions with Ets-1 and Ets-2 in the Transcriptional Activation of the Human Stromelysin Promoter* , 1999, The Journal of Biological Chemistry.

[54]  Z. Werb,et al.  The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter , 2000, Oncogene.

[55]  C. Garvie,et al.  Structural studies of Ets-1/Pax5 complex formation on DNA. , 2001, Molecular cell.

[56]  N. Bhat,et al.  Human ETS1 oncoprotein. Purification, isoforms, -SH modification, and DNA sequence-specific binding. , 1992, The Journal of biological chemistry.